1Asakawa H,Tokunaga K, Kawakami F. Comparison of risk factors of macacrovascular. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanses type 2 diabetes mellitus patients. Diabetes Comp,2000,14:307-313.
2Nishimoto Y,Miyazaki Y,Toki Y,et al. Enhanced secretion of insulin plays a role in the development of atherosclerrois and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina. J Am Coll Ca
3nd ed. Washington, DC: US Gouvemment Printing Ofice, 1995.233-257.2.Lehto S, Ronnemaa T, Pyorala K, et al. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patient with type Ⅱ diabetes.
4Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In:Harris MI,Cowie CC,Stem MP, et al,editors. Diabetes in America.
5UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional tratment and risk of complications in patients with type 2 diabetes (UKPDS:33) .Lancet, 1998,22:937-942.
6UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes: UKPDS 38. BM J, 1998,317:703-713.
7Tumer RC,Millns H,Neil HAW,et al. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus (UKPDS 23). BMJ, 1998,316:823.
8Bonora E,Willeit J,Kiechl S,et al. U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: the Bruneck Study. Diabetes Care, 1998,21:221-230.
9Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term result of the kumamoto study on optimal diabetes control in type 2 diabetes patients. Diabetes Care,2000,23(Suppl 2): B21-B29.
